FDA Inspection 1180923 — South Berwick Pharmacy Seacoast Compounding, Inc.

South Berwick Pharmacy Seacoast Compounding, Inc. — FEI 3005636572

The FDA completed an inspection of South Berwick Pharmacy Seacoast Compounding, Inc. on Sep 30, 2022 in South Berwick, ME. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 30, 2022
Fiscal Year
2022
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
South Berwick, ME (United States)

Citations

IDCFRDescription
18933FDCA 501(a)(2)(A)Vermin, production area
18936FDCA 501(a)(2)(A)Non-microbial contamination, production area
18938FDCA 501(a)(2)(A)Hazardous drugs, prevention of cross-contamination
21377FDCA 501(a)(2)(A)Use of non-pharmaceutical grade components